# 2025-21173: Importer of Controlled Substances Application: Benuvia Operations, LLC

2025-21173, Importer of Controlled Substances Application: Benuvia Operations, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26, effective 2025-11-26 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21173
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21173
- Title: Importer of Controlled Substances Application: Benuvia Operations, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54378
- Published: 2025-11-26
- Effective: 2025-11-26
- Comments close: 2025-12-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Benuvia Operations, LLC wants to become an official importer of some powerful controlled substances like Ibogaine and Tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by December 26, 2025. This move could shake up the import scene and means Benuvia might soon handle these substances legally, with all eyes on the deadline!

## Abstract

Benuvia Operations, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Benuvia applied to import listed controlled drugs: benefit, medium. Benuvia Operations, LLC applied on October 2, 2025 to be registered as an importer of several controlled substances, including Schedule I drugs (for example, Ibogaine, MDMA, DMT, mescaline, and tetrahydrocannabinols) and a Schedule II dronabinol oral solution. If registered, the company would be au…
- Stakeholders can comment or request hearing: benefit, low. Registered bulk manufacturers of the affected drug classes and applicants may submit electronic comments or objections, or file a written request for a hearing, on or before December 26, 2025. Comments must be submitted through Regulations.gov and hearing requests must be sent to the DEA addresses…
- Import authorization excludes finished commercial dosage forms: cost, medium. The notice states authorization will be limited to importing bulk active pharmaceutical ingredients, dosage forms, and samples for product development and customer support, and will not extend to importing FDA-approved or non‑approved finished dosage forms for commercial sale. Applicants whose comm…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21173 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21173/importer-of-controlled-substances-application-benuvia-operations-llc)
- [2025-21173 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21173.pdf)

## Related
- [Previous: 2025-21172, Uniform Administrative Requirements, Cost Principles, and Audit Requirements](https://policyrisk.com/federal-register/2025-21172)
- [Next: 2025-21174, Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.](https://policyrisk.com/federal-register/2025-21174)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21173 (as of 2026-06-08).
